Our data showed that the percentage of CD11b-positive cells was increased after 10058-F4 treatment, illustrating that inhibition of c-Myc expression promoted the primary AML cells to differentiate to mature cells (Figure 6B). Here, MYC is linked to acute myeloid leukemia.